Peginterferon alfa‐2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

BACKGROUND: The management of patients with chronic hepatitis C who have relapsed or failed to respond to interferon based therapies is an important issue facing hepatologists. AIMS: We evaluated the efficacy and safety of peginterferon alfa‐2a (40KD) plus ribavirin in this population by conducting...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sherman, M, Yoshida, E M, Deschenes, M, Krajden, M, Bain, V G, Peltekian, K, Anderson, F, Kaita, K, Simonyi, S, Balshaw, R, Lee, S S
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2006
Soggetti:
Hepatitis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860092/
https://ncbi.nlm.nih.gov/pubmed/16709661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.083113
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi